Jason Rich

Jason Rich has a diverse background in engineering and manufacturing roles within the biopharmaceutical industry. Jason is currently the Vice President, Global Head of Engineering at Abzena, a bioconjugate- and biologics-focused Contract Development and Manufacturing Organization (CDMO). Prior to this, they served as the Executive Director, Manufacturing at Taysha Gene Therapies. Jason has also held positions at other prominent companies such as GSK, Pfizer, Hospira, Novartis Vaccines and Diagnostics, and GlaxoSmithKline Biologicals, where they gained extensive experience in engineering, maintenance, and manufacturing. Jason's career began at Merck as an Engineer, specializing in Biological Manufacturing Engineering Support.

Jason Rich attended the Georgia Institute of Technology from 1991 to 1996, where they obtained a Bachelor's degree in Mechanical Engineering.